165 related articles for article (PubMed ID: 24466274)
1. MiR-26a promotes ovarian cancer proliferation and tumorigenesis.
Shen W; Song M; Liu J; Qiu G; Li T; Hu Y; Liu H
PLoS One; 2014; 9(1):e86871. PubMed ID: 24466274
[TBL] [Abstract][Full Text] [Related]
2. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation.
Guan Y; Yao H; Zheng Z; Qiu G; Sun K
Int J Cancer; 2011 May; 128(10):2274-83. PubMed ID: 20658525
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
[TBL] [Abstract][Full Text] [Related]
5. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.
Lu J; He ML; Wang L; Chen Y; Liu X; Dong Q; Chen YC; Peng Y; Yao KT; Kung HF; Li XP
Cancer Res; 2011 Jan; 71(1):225-33. PubMed ID: 21199804
[TBL] [Abstract][Full Text] [Related]
6. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.
Deng J; He M; Chen L; Chen C; Zheng J; Cai Z
PLoS One; 2013; 8(10):e76450. PubMed ID: 24116110
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
Zhang L; Li Z; Gai F; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.
Jiang DS; Wang YW; Jiang J; Li SM; Liang SZ; Fang HY
Int J Mol Med; 2014 Jul; 34(1):307-12. PubMed ID: 24788552
[TBL] [Abstract][Full Text] [Related]
10. MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells.
Lin G; Liu B; Meng Z; Liu Y; Li X; Wu X; Zhou Q; Xu K
Exp Cell Res; 2017 Mar; 352(2):364-374. PubMed ID: 28237093
[TBL] [Abstract][Full Text] [Related]
11. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells.
Zhao HM; Wei W; Sun YH; Gao JH; Wang Q; Zheng JH
Tumour Biol; 2015 Sep; 36(9):6867-73. PubMed ID: 25846738
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
Si Z; Yu L; Jing H; Wu L; Wang X
J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
[TBL] [Abstract][Full Text] [Related]
15. miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.
Jiang H; Qu L; Wang Y; Cong J; Wang W; Yang X
Biomed Pharmacother; 2014 Mar; 68(2):163-9. PubMed ID: 24456664
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
Wu Z; Lu B; Li X; Miao W; Li J; Shi Y; Yu W
Clin Exp Pharmacol Physiol; 2018 May; 45(5):444-451. PubMed ID: 29143362
[TBL] [Abstract][Full Text] [Related]
17. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
[TBL] [Abstract][Full Text] [Related]
19. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
20. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.
Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R
Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]